ArticleFrontiers in neurology2025

Safety profile and efficacy of secukinumab in the treatment of autoimmune myasthenia gravis: a single-center retrospective study.

Shuangmei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.